VYCO

Vycor Medical, Inc. VYCO

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode VYCO CMPD RMSL FZMD TDSGF HLYK TBRIF FNAM RSCF CLABF
6M 47.83 % -23.37 % -82.65 % -71.43 % -12.41 % -1.13 % -46.36 % 0.00 % 6.00 % -99.98 %
YTD 142.86 % -19.95 % -78.75 % -71.43 % -41.68 % -2.78 % -80.24 % -75.00 % 10.42 % -99.98 %
1Y 142.86 % -22.59 % -78.21 % -83.33 % -48.69 % -22.22 % -75.63 % -75.00 % 23.26 % -99.99 %
3Y 87.28 % 1.67 % -86.12 % -87.50 % -78.94 % -68.18 % -88.37 % -99.97 % -13.26 % -100.00 %
5Y 233.33 % -51.20 % -17.07 % -81.82 % -83.80 % -84.78 % -96.59 % -99.98 % -91.17 % -100.00 %
10Y -78.75 % 35.56 % -99.86 % -91.67 % -83.80 % -95.00 % -80.01 % -99.99 % 10.42 % -100.00 %
From the beginning -86.92 % -93.49 % -100.00 % -99.92 % -83.80 % -95.00 % -80.01 % -100.00 % -95.09 % -100.00 %

Dividend

Fuse Medical, Inc.